support@activebiopharma.com
English
Menu
主页
产品目录
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF材料
关于我们
定制合成
订单和支付
联系我们
Cas号索引 6
主页
/
Cas号索引 6
Cas号索引
1
2
3
4
5
6
7
8
9
产品名字索引
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CAS
化学名称
编号
分子式
6296-53-3
3-乙酰氨基邻苯二甲酸酐
ABP005071
C10H7NO4
618-58-6
3,5-二溴苯甲酸
ABP005056
C7H4Br2O2
6786-30-7
N/A
ABP005043
C10H10O2
60758-87-4
3,4-二乙氧基苯腈
ABP005038
C11H13NO2
60023-36-1
3-(溴甲基)哒嗪
ABP005004
C5H5BrN2
641571-11-1
3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺
ABP004988
C11H10F3N3
65537-54-4
3-(3-BROmOPHENYL)PROPAN-1-OL
ABP004966
C9H11BrO
62561-76-6
3-(2-噻吩基)-D-丙氨酸
ABP004961
C7H9NO2S
63720-37-8
3-(1-氨基乙基)苯酚
ABP004947
C8H11NO
62224-19-5
5-溴噻吩-2-甲酸甲酯
ABP004924
C6H5BrO2S
6318-74-7
2-氨基-4,5-二苯基噻唑
ABP004912
C15H12N2S
62150-44-1
4-溴-2-氰基吡啶 1-氧化物
ABP004881
C6H3BrN2O
627543-03-7
2-OxazoliDinone, 5-(aminomethyl)-3-(3-fluoro-4-ioDophenyl)-, (5S)-
ABP004828
C10H10FIN2O2
6566-42-3
2-Naphthalenecarboxylic acid, 4-(acetyloxy)-
ABP004800
C13H10O4
69226-20-6
2-methyl-thiomorpholin-3-one
ABP004795
C5H9NOS
603-83-8
2-甲基-3-硝基苯胺
ABP004789
C7H8N2O2
60518-59-4
2-甲基-5-氨基-2H-吲唑
ABP004785
C8H9N3
67510-95-6
2-甲基-1-(对-甲苯基)丙-2-胺
ABP004780
C11H17N
66952-65-6
2-hyDroxy-N,N-Dimethyl-3-nitrobenzamiDe
ABP004759
C9H10N2O4
6064-63-7
DL-α-羟基己酸
ABP004758
C6H12O3
61719-60-6
1,3-二氢-7-硝基-2H-咪唑并[4,5-c]吡啶-2-酮
ABP004736
C6H4N4O3
67765-42-8
5-甲氧基-[1,3]苯并恶嗪-2,4-二酮
ABP004729
C9H7NO4
603-84-9
2-氯-3-硝基苯酚
ABP004664
C6H4ClNO3
« 上一页
57
58
59
60
61
62
63
64
65
66
下一页 »
Cas号索引
1
2
3
4
5
6
7
8
9
产品名字索引
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Copyright © 2015-2025 活性医药. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll